UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000029595
Receipt number R000033786
Scientific Title The evaluation for Improving cognitive function of elderly patients in intensive care unit with Unibo
Date of disclosure of the study information 2017/12/01
Last modified on 2023/04/21 11:06:18

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The evaluation for Improving cognitive function of elderly patients in intensive care unit with Unibo

Acronym

The evaluation for Improving cognitive function of elderly patients in intensive care unit with Unibo

Scientific Title

The evaluation for Improving cognitive function of elderly patients in intensive care unit with Unibo

Scientific Title:Acronym

The evaluation for Improving cognitive function of elderly patients in intensive care unit with Unibo

Region

Japan


Condition

Condition

Elderly individuals aged 65 years or above who are admitted to the advanced medical emergency center

Classification by specialty

Psychiatry Emergency medicine Intensive care medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Robot Assisted Therapy(RAT) will be carried out using Unirobot as a substitute for animals in animal therapy. Besides helping to reduce cognitive decline in elderly inpatients with RAT, the robot will also take on a portion of what is equivalent to the social activity support provided by care professionals after discharge. We also aim to reduce the relevant medical costs incurred through the reduction of long-term cognitive decline.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The Japanese version of the ADAS-Cog subtest (hereafter referred to as ADAS-Jcog) will be used to capture the chronological changes in cognitive function brought about by the effects of intervention. The frequency of test administration is once a week. The study adopts an A-B-A-B design, and because of the short hospitalization period in the acute care ward, A (nonintervention; no Unirobot) and B (intervention with Unirobot) will be evaluated every two weeks. The scores between A and B will then be reviewed by statistical analysis.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Behavior,custom Other

Interventions/Control_1

Set up a Unirobot at the bedside of a patient The effect of the intervention will utilize the Alzheimer's Disease Assessment Scale-cognitive component-Japanese version in order to understand the change of cognitive function over time. Inspection frequency is once a week. Study design is designated as A-B-A-B and evaluate A (No intervention: without Unirobot) and B (Intervention: with Unirobot) every two weeks due acute care ward patients stay hospital shorter and points of A and B are considered in statistical processing. Expected human research subject is 600 due approximately 300 elderly people is adopted to the advanced emergency medical service center annually.

Interventions/Control_2

Set up a Unirobot at the bedside of a patient The effect of the intervention will utilize the Alzheimer's Disease Assessment Scale-cognitive component-Japanese version in order to understand the change of cognitive function over time. Inspection frequency is once a week. Study design is designated as A-B-A-B and evaluate A (No intervention: without Unirobot) and B (Intervention: with Unirobot) every two weeks due acute care ward patients stay hospital shorter and points of A and B are considered in statistical processing. Expected human research subject is 600 due approximately 300 elderly people is adopted to the advanced emergency medical service center annually.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

Elderly individuals aged 65 years or above who are admitted to the advanced medical emergency center.

Key exclusion criteria

All individuals too bad situation of one's body to accept of this reserch.

Target sample size

600


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Takehiro Kitawaki

Organization

Saitama Medical University

Division name

Support for medical personnel development center kawagoe branch

Zip code


Address

1981 Kamoda Kawagoe-shi Saitama-ken

TEL

0492283755

Email

mekita@saitama-med.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Takehiro Kitawaki

Organization

Saitama Medical University

Division name

Support for medical personnel development center kawagoe branch

Zip code


Address

1981 Kamoda Kawagoe-shi Saitama-ken

TEL

0492283755

Homepage URL


Email

mekita@saitama-med.ac.jp


Sponsor or person

Institute

Saitama Medical University

Institute

Department

Personal name



Funding Source

Organization

Saitama Medical University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 12 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2017 Year 11 Month 01 Day

Date of IRB

2017 Year 12 Month 01 Day

Anticipated trial start date

2017 Year 12 Month 01 Day

Last follow-up date

2019 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 10 Month 17 Day

Last modified on

2023 Year 04 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033786


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name